Literature DB >> 30507998

Effects of polymorphisms in APOB, APOE, HSD11β1, PLIN4, and ADIPOQ genes on lipid profile and anthropometric variables related to obesity in children and adolescents.

Caroline C Gasparin1, Neiva Leite2, Luciane V Tureck1, Ricardo L R Souza1, Gerusa E Milano-Gai2, Larissa R Silva2, Wendell A Lopes2, Lupe Furtado-Alle1.   

Abstract

Genes can influence lipid profile and anthropometric variables related to obesity. The present study aimed to verify if variants of the APOE, APOB, ADIPOQ, HSD11β1, and PLIN4 genes are associated with lipid levels or anthropometric variables in a sample comprised of 393 Euro-Brazilian children and adolescents. DNA was genotyped by TaqMan allelic discrimination assay. The ε4 and ε2 alleles of the APOE gene were associated respectively with lower high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels (p=0.015 and p=0.012, respectively), while the ε3 allele was associated with higher abdominal circumference (p=0.0416) and excess weight (p=0.0001). The G allele (rs846910) of the HSD11β1 gene was also associated with excess weight (p=0.039). No other association was found. Our results indicate that the ε4 and ε2 alleles could contribute to lower HDL-C and LDL-C levels, respectively, furthermore, the ε3 allele and the G allele (rs846910) of HSD11β1 gene may be risk factors for excess of weight.These findings are very important because we observed that some genetic variants influence the lipid profile and anthropometric variables early in life.

Entities:  

Year:  2018        PMID: 30507998      PMCID: PMC6415595          DOI: 10.1590/1678-4685-GMB-2017-0195

Source DB:  PubMed          Journal:  Genet Mol Biol        ISSN: 1415-4757            Impact factor:   1.771


Introduction

Dyslipidemia is closely related to the development of cardiovascular and cerebrovascular diseases, such as atherosclerosis, acute myocardial infarction, ischemic heart disease, and cerebrovascular accident, and therefore of great relevance for public health (ANVISA, 2011; Maria ). It is estimated that 53% of American adults have lipid abnormalities (Tóth ). In Brazil, according to Alcântara Neto , the prevalence of dyslipidemia among children and adolescents enrolled in the public school system was 25.5%. They also found a positive association between dyslipidemia and overweight (Alcântara Neto ). Worldwide, in 2015, the number of overweight children under five years old had been estimated at more than 42 million (WHO, 2016). Dyslipidemias, as well as obesity, are mainly multifactorial traits, influenced by the environment, genetic factors, and life habits. Polymorphisms of the APOB, APOE, ADIPOQ, PLIN4, and HSD11β1 genes are important examples of genetic causes associated with dyslipidemias and obesity. The genetic variants selected for this study seem to have functional effects, being involved in lipid metabolism and features related to obesity (Innerarity ; Soria ; Myant, 1993; Arita ; Foley, 2005; Greenow ; Heeren ; Lara-Castro ; Gambineri ; Richardson ). The APOE glycoprotein plays an important role in metabolism, transport, and redistribution of molecules that carry cholesterol and other lipids (Poirier, 2005). It is encoded by a gene of the same name (19q13.2) and mediates the uptake of chylomicrons, very low-density lipoprotein (VLDL) and intermediate density lipoprotein (IDL) (Mahley, 1988; Weisgraber ). The ε2, ε3, and ε4 alleles (rs7412: NM_000041.3:c.526C > T and rs429358: NM_000041.3:c.388T > C) are combined in two important positions (Weisgraber ), producing therefore the three APOE major isoforms E2 (Cys 112, Cys 158), E3 (112 Cys, Arg 158), and E4 (Arg 112, Arg 158) (Foley 2005; Greenow ; Heeren ). ApoB-100 is encoded by the APOB gene (2p24.1) and it is present on the surface of LDLs (Blackhart ; Innerarity ). The R3500Q mutation (rs5742904: NM_000384.2:c.10580G > A) leads to diminished affinity for its receptor (Innerarity ; Soria ; Myant, 1993). PLIN4 (19p13.3; Ensembl 2015) participates in the Perilipin/ADRP/TIP47 (PAT) family of lipid storage droplet (LSD) proteins and appears to be involved in the storage of lipids in adipocytes (Brasaemle, 2007). The rs8887 (NM_001080400.1:c.*2270A > G) polymorphism is situated in the 3’UTR region of PLIN4 gene. The less frequent allele of this site may induce a reduction of up to 20% in the PLIN4 level due to the creation of a miR-522 binding site in the 3’UTR region of the gene (Richardson ). The human gene encoding adiponectin, ADIPOQ gene (3q27), is the most expressed gene in adipose tissue (Maeda ). Obesity, and in particular the accumulation of abdominal visceral fat, as well as type 2 diabetes mellitus, coronary disease, and arterial hypertension are accompanied by a reduction of serum adiponectin (Arita ; Lara-Castro ). The SNP of the ADIPOQ gene was rs1501299: NM_001177800.1:c.214+62G > T. The HDS11β1 gene (1q32.2; Ensembl, 2015) encodes the enzyme hydroxysteroid dehydrogenase type 1 (11β-HSD1), which is responsible for the conversion of inactive to active cortisol, in addition to regulating the interaction of cortisol with glucocorticoid receptors (Bujalska ). Transgenic rats that overexpress this enzyme in adipose tissue develop visceral obesity, insulin resistance, hyperglycemia, and hyperlipidemia (Masuzaki ). Among its polymorphisms are rs846910 (NM_001206741.1:c.-48-2986A > G), which corresponds to a non-coding region SNP of the HSD11β1 gene, and rs12086634 (NM_001206741.1:c.332-29T > G), which occurs in an enhancer region in intron 3 (Gambineri ). Hence, the aim of the present study was to investigate possible influences of the PLIN4 (rs8887), APOB (rs5742904), ADIPOQ (rs1501299), HSD11β1 (rs848910 and rs12086634), and APOE (rs7412 and rs429358; alleles ε2, ε3, and ε4) genes on lipid and glucose levels, abdominal circumference, and obesity in a sample of children and adolescents from a population in southern Brazil.

Subjects and Methods

Subjects

The sample was comprised of 393 Euro-Brazilians (13.54 ± 0.095 years old) living in Curitiba, PR, of which 143 were eutrophic and 250 overweight. Of these 393 individuals, 128 were girls (21.09% eutrophic and 78.91% overweight) and 265 were boys (43.94% eutrophic and 56.06% overweight). This study was approved by the Institutional Ethics Committee and informed consent was signed by participants and their parents or legal guardians. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m). Age- and sex-specific BMI z-score and percentiles were calculated using CDC 2000 growth charts (Kuczmarski ). Eutrophic was defined as a < 85 percentile, overweight as a ≥85 percentile, and obesity as ≥95 percentile. The abdominal circumference (AC) was measured in centimeters (cm) at the level of the iliac crest. Thus, subjects were classified as eutrophic (percentile < 85) and overweight/obese (percentile ≥ 85) (Kuczmarski ). Blood samples were collected in the morning after 12 hours of fasting to perform measurements of glucose (Glu), triglycerides (TG), total cholesterol (TC), and high density lipoprotein cholesterol (HDL-C) by standard automated methods. Low density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald equation (Friedewald ), for TG levels below 200 mg/dL.

Genotyping assays

DNA was extracted from peripheral blood by a salting-out method (Lahiri and Numberger, 1991) and was diluted to 20 ng/μL. All SNPs were genotyped by TaqMan allelic discrimination assay on StepOnePlus real time PCR systems (Applied Biosystems, USA). Each reaction contained 3.0 μL of Master Mix (2X), 1.7 μL of ultrapure water, 0.3 μL of primer and 3.0 μL of DNA. The reactions were performed according to the following protocol: 50 °C for 2 min, 95 °C for 10 min, and 50 cycles of 95 °C for 15 s and 62 ºC for 1 min.

Statistical analysis

Samples were classified into two groups, eutrophic and overweight (overweight + obese), categorized into above and below the median for age, AC, Glu, TC, LDL-C, HDL-C and TG levels. Chi-square tests were performed using Clump (Jakobsson and Rosenberg, 2007) to test for Hardy-Weinberg equilibrium and to compare allele proportions between groups above and below the median and also between eutrophic and overweight. Logistic regression analyses were performed to identify variables influencing serum glucose, lipid concentrations, and AC. False discovery rate (FDR) corrections (Benjamini and Hochberg, 1995) were performed for multiple testing. The significance level adopted was 0.05 (5%).

Results

A descriptive analysis of the sample, displaying the variables considered in this study, is shown in Table 1. Significantly higher frequencies were found for the ε4 allele in the group below the HDL-C median (p=0.0001), and for the ε2 allele in the group below the LDL-C median (p=0.0001). Furthermore the ε3 allele was associated with higher AC and excess weight (p=0.0001). The allele frequencies are shown in Table 2. Logistic regression analysis was done using stratified TC as below and above the median as the dependent variable, and for the polymorphisms analyzed (dominant model for APOE gene, in which ε4 is dominant over ε2; for the other polymorphisms, dominant, recessive, and additive models were tested), gender, AG, and anthropometric classification as independent variables. The same logistic regression analysis design was performed using LDL-C, HDL-C, TG, glucose, and AC as the dependent variable and maintaining the same independent variables. We identified the APOE gene ε4 allele as a contributing factor in reducing HDL-C levels (β = -0.29 ± 0.08, p=0.015) and the ε3 allele as a risk factor for higher AC measures (β = -0.24 ± 0.08, p=0.041). We also found that obesity and overweight are independent risk factors for higher triglyceride levels (β = 0.30 ± 0.08, p=0.021).
Table 1

Descriptive statistics for age, lipid profile, glucose, and abdominal circumference of the 393 individuals analyzed in this study.

Variable * N ** Mean ± SEMedianVarianceSDBoys mean ± SEGirls mean ± SE
Age39313.54 ± 0.09513.963.561.8913.54 ± 0.1213.54 ± 0.17
HDL-C (mg/dL)36947.59 ± 0.8946.00116.20310.7845.44 ± 0.6351.69 ± 1.02
LDL-C (mg/dL)26291.36 ± 1.8587.50898.18729.9789.93 ± 2.5392.94 ± 2.72
TG (mg/dL)36799.17 ± 2.8881.743055.9255.2896.06 ± 3.35105.05 ± 5.41
TC (mg/dL)262162.67 ± 2.19158.0951261.9635.52160.42 ± 2.98165.19 ± 3.24
Glu (mg/dL)38789.50 ± 0.5689.00120.84210.9990.60 ± 0.7287.25±0.83
AC (cm)29183.69 ± 1.0781.50333.00118.2580.77 ± 1.2192.25±1.94

High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Triglycerides (TG), Total Cholesterol (TC), Glucose (Glu), Abdominal Circumference (AC).

393 individuals were analyzed.

Table 2

Comparisons of allele frequencies between groups below and above the median for the analyzed variables, and between eutrophic and overweight/obese individuals.

AllelesAbove TC (mg/dL) medianBelow TC (mg/dL) medianAbove LDL-C (mg/dL) medianBelow LDL-C (mg/dL) MedianAbove TG (mg/dL) medianBelow TG (mg/dL) medianAbove HDL-C (mg/dL) medianBelow HDL-C (mg/dL) medianAbove AC (cm) medianBelow AC (cm) medianEutrophicOverweight / Obese
ε2 (APOE gene)3.57 ± 0.28 (6)7.14 ± 0.55 (12)1.83 ± 0.14 (3)8.72 ± 0.66 (15) p=0.00014.84 ± 0.31 (12)5.23 ± 0.32 (14)4.92 ± 0.30 (13)5.12 ± 0.32 (13)6.25±0.49 (10)2.31 ± 0.15 (5)3.70±0.25 (8)5.36 ± 0.29 (18)
ε3 (APOE gene)82.14 ± 6.34(138)81.55 ± 6.29 (137)82.93 ± 6.48(136)80.81 ± 6.16 (139)78.22 ± 4.97 (194)79.10 ± 4.83(212)84.85 ± 5.22 (224)72.44 ± 4.54(184)71.88 ± 5.68(115) p=0.000171.30 ± 4.85(154)76.39 ± 5.20 (165)78.87 ± 4.30 (265) p=0.0001
ε4 (APOE gene)14.29 ± 1.35 (24)11.31 ± 1.31 (19)15.24 ± 1.32 (25)10.47 ± 1.30 (18)16.94 ± 1.35 (42)15.67 ± 1.24 (42)22.44 ± 1.70 (27)10.23 ± 0.88 (57) p=0.000121.87 ± 2.17 (35)26.39 ± 1.95 (57)19.91 ± 1.59 (43)15.77 ± 1.12 (53)
G (rs846910 HSD11β1 gene)88.96 ± 2.52 (137)90.85±2.25 (149)88.19 ± 2.69 (127)91.38 ± 2.13 (159)88.75 ± 2.04 (213)84.8 ± 2.27 (212)87.5 ± 2.07 (224)85.59 ± 2.28 (202)87.86 ± 2.76 (123)80.58±2.76 (166)80.84 ± 2.69 (173)89.42 ± 1.74 (279) p=0.039
High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Triglycerides (TG), Total Cholesterol (TC), Glucose (Glu), Abdominal Circumference (AC). 393 individuals were analyzed. Furthermore, we observed that the A allele (rs846910) of the HSD11β1 gene was associated with excessive weight (p=0.039, Chi-square test). It is known that there is variation in metabolic processes inherent to gender, so we conducted the same analyses separately for each gender. We observed that in girls the alleles ε2 and ε4 of the APOE gene were associated with LDL-C below the median (p=0.0001 by Chi-square test) and HDL-C below the median, independently of the other analyzed variables (β = -0.34 ± 0.08, p=0.0039) (Table 3). Furthermore, eutrophic girls had lower mean TG levels than obese or overweight girls (β = 0.30 ± 0.08, p=0.0039). Regarding boys, we observed that the ε2 allele is associated to lower LDL-C levels (p=0.019 by Chi-square test) (Table 3).
Table 3

Comparisons of APOE allele frequencies between groups below and above the median for the analyzed variables, and between eutrophic and overweight/obese individuals stratified by sex.

Alleles in Girls GroupCT (mg/dl)LDL-C (mg/dl)TG (mg/dl)HDL-C (mg/dl)AC (cm)Obesity status
Above the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianEutrophicOverweight/ obese
ε2 (APOE - rs7412 and rs429358)2.33±0.25 (2)7.14 ± 0.85 (5)1.22 ± 0.14 (1)8.11 ± 0.94 (6) p=0.00012.44 ± 0.27 (2)6.25±0.70 (5)5.21 ± 0.53 (5)3.03 ± 0.37 (2)0.00 ± 0.00 (0)0.00 ± 0.00 (0)3.12 ± 0.55 (1)4.55 ± 0.40 (6)
E3 (APOE - rs7412 and rs429358)83.72 ± 9.03 (72)82.86 ± 9.90 (58)84.15 ± 9.29 (69)82.43±9.58 (61)82.93 ± 9.16 (68)81.25±9.08 (65)87.5 ± 8.93 (84)74.24 ± 9.14 (49)66.67 ± 11.11 (24)68.75 ± 12.15 (22)84.38 ± 14.91 (27)81.06 ± 7.06 (107) p=0.0001
ε4 (APOE - rs7412 and rs429358)13.95 ± 1.74 (12)10.00 ± 1.86 (7)14.63 ± 1.75 (12)9.46 ± 1.81 (7)14.63 ± 1.86 (12)12.5 ± 1.98 (10)7.29 ± 1.16 (7)22.73 ± 3.15 (15) p=0.003933.33 ± 5.56 (12)31.25±5.52 (10)12.5 ± 2.71 (4)14.39 ± 1.60 (19)
Alleles in Boys GroupCTLDL-CTGHDL-CAC
Above the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianAbove the medianBelow the medianEutrophicOverweight/ obese
ε2 (APOE - rs7412 and rs429358)5.81 ± 0.63 (5)6.38 ± 0.66 (6)3.84 ± 0.44 (3)7.84 ± 0.78 (8) p=0.0196.79 ± 0.53 (11)4.17 ± 0.30 (8)5.00 ± 0.37 (9)5.68 ± 0.43 (10)7.35 ± 0.63 (10)2.91 ± 0.22 (5)3.80 ± 0.28 (7)5.88 ± 0.41 (12)
ε3 (APOE - rs7412 and rs429358)81.40 ± 8.78 (70)79.79 ± 8.23 (75)79.49 ± 9.00 (62)81.37 ± 8.06 (83)74.69 ± 5.87 (121)79.16 ± 5.71 (152)81.67 ± 6.09 (147)72.73 ± 5.48 (128)73.53 ± 6.30 (100)71.51 ± 5.45 (123)75.00 ± 5.53 (138)77.45 ± 5.42 (158)
ε4 (APOE - rs7412 and rs429358)12.79 ± 1.91 (11)13.83 ± 1.98 (13)16.67 ± 2.28 (13)10.79 ± 1.67 (11)18.52 ± 1.92 (30)16.67 ± 1.47 (32)13.33 ± 1.31 (24)21.59 ± 2.01 (38)19.12 ± 2.18 (26)25.58±2.16 (44)21.20 ± 1.82 (39)16.67 ± 1.52 (34)

Discussion

Blood lipid levels are influenced by environmental and genetic factors (Crook, 2012), and it is known that LDL-C is the primary target for reducing cardiovascular risk (Catapano ). In our study, as shown in Figure 1, it was observed that the APOE ε2 allele was associated with lower LDL-C levels in the total sample, as well as in girls and boys, which is consistent with the known protective effect of this allele (Frikke-Schmidt ; Bennet ; Fuzikawa ; Ward ; Nascimento ; Bazzaz ; Ferreira ). Our finding is particularly relevant considering that the protective effect of the ε2 allele is usually observed in adults, but in our study we observed that it is also present in children and adolescents, and therefore can contribute to lower LDL-C levels early in life.
Figure 1

Relationships between allelic variants and analyzed variables.

The APOE-ε4 allele seems to be associated with lower HDL-C levels, which support the notion that the ε4 allele is an atherogenic risk factor (Frikke-Schmidt ; Bennet ; Fuzikawa ; Ward ). Being related to lower HDL-C levels, responsible for cholesterol reverse transport, this allele could contribute to higher cholesterol levels, and this is especially worrisome in children, considering all possible and severe comorbidity (ANVISA, 2011; Maria ; Crook, 2012). Besides its association with the lipid profile, some studies have demonstrated that the APOE gene influences characteristics of obesity (Volcik ; Tabatabaei-Malazy ). According to the Atherosclerosis Risk in Communities (ARIC) study, the apo E genotypes were associated with BMI following the order: apo E4 > apo E3 > apo E2 (Volcik ). Srinivasan , who analyzed a sample of children and adolescents, similar to this study, found that the apo E3 group showed significant associations with obesity measures and lipoprotein variables. Our work is in agreement with Sun who also found some increased variables, such as BMI and LDL-C, in ε3 allele carriers when compared to ε2 allele carriers in the non-metabolic syndrome group (Sun ). Some studies also have associated the ε4 allele with features related to obesity in different populations (Tabatabaei-Malazy ; Alharbi ). Therefore, these polymorphisms in the APOE gene influence both lipid profile and traits related to obesity. It is important to highlight the relevance of studies involving this gene, especially in the young. We found a relationship between the G allele of the HSD11β1 gene rs846910 polymorphism and higher AC measurements. Some studies have demonstrated different effects of this polymorphism on serum lipid levels and other associated characteristics (Nair ; Duran-Gonzalez ; Dujic ). Different from this study, Durán-Gonzalez observed an association between the A allele and higher triglyceride levels, and according to some studies this polymorphism could be associated to metabolic syndrome (Nair ; Duran-Gonzalez ; Dujic ). However, Turek found that the A allele ws associated with higher HDL-C levels only in women. Furthermore, it is relevant to consider that a possible linkage disequilibrium might exist with another polymorphism in the HSD11β1 gene, and another allele could be the cause of an altered lipid profile or features related to obesity (Malavasi ). Although our study had relevant findings, we recognize that the small sample size is a limitation, thus generalizability should be done with caution, and studies with larger samples should be done. In summary, we found that in children and adolescents, as in adults, the ε4 and ε3 alleles could be considered a contributing factor for dyslipidemia and traits related to obesity, respectively, while the ε2 allele seems to be a protective factor, contributing to lower LDL-C and higher HDL-C levels. Furthermore, the HSD11β1 gene G allele seems to be related to obesity. Considering that effects may start early in life, a precocious intervention could be planned, therefore preventing many complications resulting from altered lipid profile and obesity.
  42 in total

Review 1.  Update on risk factors for atherosclerosis: the role of inflammation and apolipoprotein E.

Authors:  Susan M Foley
Journal:  Medsurg Nurs       Date:  2005-02

Review 2.  Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.

Authors:  Joerg Heeren; Ulrike Beisiegel; Thomas Grewal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-22       Impact factor: 8.311

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

4.  A transgenic model of visceral obesity and the metabolic syndrome.

Authors:  H Masuzaki; J Paterson; H Shinyama; N M Morton; J J Mullins; J R Seckl; J S Flier
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

5.  Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.

Authors:  Kelly A Volcik; Ruth Ann Barkley; Richard G Hutchinson; Thomas H Mosley; Gerardo Heiss; A Richey Sharrett; Christie M Ballantyne; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2006-06-07       Impact factor: 4.897

Review 6.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

Review 7.  Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.

Authors:  Judes Poirier
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

8.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

9.  Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.

Authors:  R Frikke-Schmidt; B G Nordestgaard; B Agerholm-Larsen; P Schnohr; A Tybjaerg-Hansen
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

10.  11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.

Authors:  S Nair; Y H Lee; R S Lindsay; B R Walker; P A Tataranni; C Bogardus; L J Baier; P A Permana
Journal:  Diabetologia       Date:  2004-05-20       Impact factor: 10.122

View more
  3 in total

Review 1.  Apolipoprotein E and Atherosclerosis.

Authors:  A D Marais
Journal:  Curr Atheroscler Rep       Date:  2021-05-10       Impact factor: 5.113

2.  Association between Selected Polymorphisms rs12086634, rs846910, rs4844880, rs3753519 of 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD11B1) and the Presence of Insulin Resistance in the Polish Population of People Living in Upper Silesia.

Authors:  Nikola Szweda-Gandor; Mirosław Śnit; Władysław Grzeszczak
Journal:  Int J Environ Res Public Health       Date:  2021-09-27       Impact factor: 3.390

3.  The correlation between APOE expression and the clinical characteristics and prognosis of patients with endometrial cancer.

Authors:  Chaoying Wu; Ting Li; Wenjun Cheng
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.